← back to search

Yingnan Yang

Harbin Medical University · CN
Area of research
Cancer Research · Building and Construction
Research interest
Research focused on Colorectal cancer and Cell growth, with related work in microRNA, Neoadjuvant therapy, Oncology. Notable publications include 'UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution', 'Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer', and 'Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma'.
h-index
citations
778
works
29
NIH funding
primary concept
email

Recent publications

RNA splicing and alternative polyadenylation profile during sheep zygotic genome activation
Biology of Reproduction 2025cited by 4position: middledoi
KDM5B impairs oocyte quality and causes embryo arrest via epigenetic regulation of spindle assembly and chromosome arrangement
Theriogenology 2025cited by 1position: firstdoi
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization
Cell Death Discovery 2024cited by 13position: middledoi
Comparative transcriptome analysis provides molecular insights into heterosis of waterlogging tolerance in Chrysanthemum indicum
BMC Plant Biology 2024cited by 6position: middledoi
Single-cell RNA sequencing reveals distinct transcriptomic profiles and evolutionary patterns in lung cancer brain metastasis
Heliyon 2024cited by 5position: lastdoi
H3K4me3 Genome-Wide Distribution and Transcriptional Regulation of Transposable Elements by RNA Pol2 Deposition
International Journal of Molecular Sciences 2024cited by 5position: middledoi
Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma
EBioMedicine 2023cited by 56position: middledoi
Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study)
International Journal of Surgery 2023cited by 41position: firstdoi
CREB1 Is Involved in miR-134-5p-Mediated Endometrial Stromal Cell Proliferation, Apoptosis, and Autophagy
Cells 2023cited by 5position: middledoi
Effects of Zearalenone on Apoptosis and Copper Accumulation of Goat Granulosa Cells In Vitro
Biology 2023cited by 4position: middledoi
<scp>chi‐miR</scp> ‐130b‐3p regulates the <scp>ZEA</scp> ‐induced oxidative stress damage through the <scp>KEAP1</scp> / <scp>NRF2</scp> signaling pathway by targeting <scp>SESN2</scp> in goat <scp>GCs</scp>
The FASEB Journal 2023cited by 4position: middledoi
miR-101–5p overexpression suppresses the proliferation of goat spermatogonial stem cells by targeting EZH2
Animal Reproduction Science 2023cited by 2position: middledoi
YBX1 mediates alternative splicing and maternal mRNA decay during pre-implantation development
Cell & Bioscience 2022cited by 37position: middledoi
Long Non-coding RNA SNHG16 Facilitates Esophageal Cancer CellProliferation and Self-renewal through the microRNA-802/PTCH1Axis
Current Medicinal Chemistry 2022cited by 26position: middledoi
Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment
Cancer Immunology Immunotherapy 2022cited by 22position: middledoi
Evaluation of wild chrysanthemums for waterlogging tolerance at the seedling stage
Euphytica 2022cited by 17position: middledoi
The adsorption and desorption behavior and mechanism research of cobalt, nickel and copper in nitrite - sulfuric acid system
Separation Science and Technology 2022cited by 11position: middledoi
Characterization of transcriptional activity during ZGA in mammalian SCNT embryo
Biology of Reproduction 2021cited by 25position: middledoi
Long non-coding RNA lnc_3712 impedes nuclear reprogramming via repressing Kdm5b
Molecular Therapy — Nucleic Acids 2021cited by 17position: middledoi
Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase Ⅱ, single-arm, exploratory research.
Journal of Clinical Oncology 2021cited by 9position: middledoi
405 Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): a phase II, single-arm, exploratory research
Regular and Young Investigator Award Abstracts 2021cited by 2position: middledoi
406 Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: a phase II, single-arm, exploratory research
Regular and Young Investigator Award Abstracts 2021cited by 1position: middledoi
The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer
Journal of Thoracic Disease 2019cited by 56position: middledoi
MicroRNA-421 promotes proliferation and invasion of non-small cell lung cancer cells through targeting PDCD4
Pathology - Research and Practice 2019cited by 12position: firstdoi
Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
Cancer Cell International 2018cited by 113position: firstdoi
A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
Oncotarget 2017cited by 18position: middledoi
siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells
Oncotarget 2017cited by 10position: middledoi
UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution
Pathology 2014cited by 238position: middledoi
Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma
Acta Histochemica 2013cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaodong Ling · Harbin Medical University11 papers (2019–2024)Jianqun Ma · Nantong University9 papers (2013–2024)Luquan Zhang · Harbin Medical University9 papers (2019–2024)Chengyuan Fang · Harbin Medical University7 papers (2019–2023)Mingtian Deng · South China Agricultural University7 papers (2021–2025)Feng Wang · Second People's Hospital of Yunnan Province6 papers (2021–2025)Dayong Zheng · Guangzhou University of Chinese Medicine6 papers (2013–2022)Yanzhong Xin · Harbin Medical University6 papers (2019–2023)Jinhong Zhu · Shanghai Medical College of Fudan University5 papers (2019–2024)Yongjie Wan · Nanjing Agricultural University5 papers (2021–2023)Xiaoyuan Wang · National University of Singapore5 papers (2021–2023)Zifei Liu · Nanjing Agricultural University5 papers (2021–2023)Jinfeng Zhang · Nanchang University4 papers (2013–2021)Yanli Zhang · Hebei Medical University4 papers (2021–2025)Yu Han · Zhejiang A & F University3 papers (2014–2018)Hao Jiang · King University3 papers (2021–2021)Baobao Chen · Nanjing Agricultural University3 papers (2021–2022)Wei Zheng · Harbin Medical University3 papers (2021–2021)Heng-heng Yuan · Harbin Medical University3 papers (2014–2018)Hongxue Meng · Harbin Medical University2 papers (2021–2023)